These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 18194706)
1. "Male lumpectomy": focal therapy for prostate cancer using cryoablation. Onik G; Vaughan D; Lotenfoe R; Dineen M; Brady J Urology; 2007 Dec; 70(6 Suppl):16-21. PubMed ID: 18194706 [TBL] [Abstract][Full Text] [Related]
2. The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Onik G; Vaughan D; Lotenfoe R; Dineen M; Brady J Urol Oncol; 2008; 26(5):500-5. PubMed ID: 18774463 [TBL] [Abstract][Full Text] [Related]
3. Rationale for a "male lumpectomy," a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up. Onik G Cardiovasc Intervent Radiol; 2008; 31(1):98-106. PubMed ID: 17593431 [TBL] [Abstract][Full Text] [Related]
4. Cryosurgical ablation of the prostate: high risk patient outcomes. Prepelica KL; Okeke Z; Murphy A; Katz AE Cancer; 2005 Apr; 103(8):1625-30. PubMed ID: 15747374 [TBL] [Abstract][Full Text] [Related]
8. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry. Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117 [TBL] [Abstract][Full Text] [Related]
9. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Eisenberg ML; Shinohara K Urology; 2008 Dec; 72(6):1315-8. PubMed ID: 18597824 [TBL] [Abstract][Full Text] [Related]
10. Salvage prostate cryoablation: initial results from the cryo on-line data registry. Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664 [TBL] [Abstract][Full Text] [Related]
11. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience. Siddiqui SA; Mynderse LA; Zincke H; Hoffmann NE; Lobo JR; Wilson TM; Kawashima A; Davis BJ; Blute ML Urology; 2007 Jul; 70(1):80-5. PubMed ID: 17656213 [TBL] [Abstract][Full Text] [Related]
12. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Ellis DS; Manny TB; Rewcastle JC Urology; 2007 Feb; 69(2):306-10. PubMed ID: 17320669 [TBL] [Abstract][Full Text] [Related]
13. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience. Barzell WE; Melamed MR Urology; 2007 Dec; 70(6 Suppl):27-35. PubMed ID: 18194708 [TBL] [Abstract][Full Text] [Related]
14. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. Ismail M; Ahmed S; Kastner C; Davies J BJU Int; 2007 Oct; 100(4):760-4. PubMed ID: 17662081 [TBL] [Abstract][Full Text] [Related]
15. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy. Ward JF; Nakanishi H; Pisters L; Babaian RJ; Troncoso P BJU Int; 2009 Aug; 104(4):490-7. PubMed ID: 19220260 [TBL] [Abstract][Full Text] [Related]
16. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970 [TBL] [Abstract][Full Text] [Related]
17. Radical prostatectomy for high-risk prostate cancer: biochemical outcome. Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167 [TBL] [Abstract][Full Text] [Related]
18. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Polascik TJ; Nosnik I; Mayes JM; Mouraviev V Urology; 2007 Jul; 70(1):117-21. PubMed ID: 17656220 [TBL] [Abstract][Full Text] [Related]
19. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound. Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973 [TBL] [Abstract][Full Text] [Related]